INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Grant or awardVerified data

Field Robert Stuart reported HUM

Director · HUMANA INC · Humana Common

Side
A
Value
—
Shares
852
Price
—
Executed
May 1, 2026
Disclosed
May 5, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
May 1 executedMay 5, 2026 disclosed

HUM · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · HUM

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    NS
    Nundy ShantanuChief Medical Officer
    HUMHUMANA INC
    Grant or award
    A—
    2,549 sh
    Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    +2dSEC FORM 4

    Evidence

    17
    MA
    Martin AaronPresident, Medicare Advantage
    HUMHUMANA INC
    Grant or award
    A—
    8,206 sh
    May 1, 2026May 5, 2026
    traded May 1, 2026
    +4dSEC FORM 4

    Evidence

    17
    SK
    Shetty Sanjay KPresident, CenterWell
    HUMHUMANA INC
    Grant or award
    A—
    9,945 sh
    May 1, 2026May 5, 2026
    traded May 1, 2026
    +4dSEC FORM 4

    Evidence

    21
    DD
    Dintenfass DavidPresident, Enterprise Growth
    HUMHUMANA INC
    Grant or award
    A—
    11.3K sh
    May 1, 2026May 5, 2026
    traded May 1, 2026
    +4dSEC FORM 4

    Evidence

    21
    RA
    Rechtin James A.President & CEO
    HUMHUMANA INC
    Grant or award
    A—
    35.6K sh
    May 1, 2026May 5, 2026
    traded May 1, 2026
    +4dSEC FORM 4

    Evidence

    21
    MJ
    Mehta JapanChief Information Officer
    HUMHUMANA INC
    Grant or award
    A—
    9,448 sh
    May 1, 2026May 5, 2026
    traded May 1, 2026
    +4dSEC FORM 4

    Evidence

    20
    Julia LetlowRSelf
    HUMHUMANA INC
    Sale
    SELL$1,001 – $15KFeb 10, 2026Mar 12, 2026
    traded Feb 10, 2026
    +30dHOUSE PTR

    Evidence

    13
    RG
    Renaudin George IIPresident, Insurance
    HUMHUMANA INC
    Option exercise
    M—
    1,035 sh
    Feb 24, 2026Feb 26, 2026
    traded Feb 24, 2026
    +2dSEC FORM 4

    Evidence

    12
    RG
    Renaudin George IIPresident, Insurance
    HUMHUMANA INC
    Tax withholding
    F$74K
    419 sh
    Feb 24, 2026Feb 26, 2026
    traded Feb 24, 2026
    +2dSEC FORM 4

    Evidence

    21
    FW
    Felter John-Paul W.SVP, Chief Accting Off & Cont.
    HUMHUMANA INC
    Grant or award
    A—
    5,669 sh
    Feb 23, 2026Feb 25, 2026
    traded Feb 23, 2026
    +2dSEC FORM 4

    Evidence

    36
    SK
    Shetty Sanjay KPresident, CenterWell
    HUMHUMANA INC
    Open-market purchase
    BUY$150K
    810 sh
    Feb 23, 2026Feb 25, 2026
    traded Feb 23, 2026
    +2dSEC FORM 4

    Evidence

    9
    FW
    Felter John-Paul W.SVP, Chief Accting Off & Cont.
    HUMHUMANA INC
    Option exercise
    M—
    165 sh
    Feb 24, 2026Feb 25, 2026
    traded Feb 24, 2026
    +1dSEC FORM 4

    Evidence

    9
    FW
    Felter John-Paul W.SVP, Chief Accting Off & Cont.
    HUMHUMANA INC
    Tax withholding
    F$15K
    84 sh
    Feb 24, 2026Feb 25, 2026
    traded Feb 24, 2026
    +1dSEC FORM 4

    Evidence

    17
    DD
    Dintenfass DavidPresident, Enterprise Growth
    HUMHUMANA INC
    Option exercise
    M—
    3,858 sh
    Feb 21, 2026Feb 24, 2026
    traded Feb 21, 2026
    +3dSEC FORM 4

    Evidence

    16
    DD
    Dintenfass DavidPresident, Enterprise Growth
    HUMHUMANA INC
    Tax withholding
    F$224K
    1,182 sh
    Feb 21, 2026Feb 24, 2026
    traded Feb 21, 2026
    +3dSEC FORM 4

    Evidence

    23
    MJ
    Mehta JapanChief Information Officer
    HUMHUMANA INC
    Option exercise
    M—
    1,682 sh
    Feb 13, 2026Feb 18, 2026
    traded Feb 13, 2026
    +5dSEC FORM 4

    Evidence

    22
    MJ
    Mehta JapanChief Information Officer
    HUMHUMANA INC
    Tax withholding
    F$78K
    430 sh
    Feb 13, 2026Feb 18, 2026
    traded Feb 13, 2026
    +5dSEC FORM 4

    Evidence

    15
    MA
    Martin AaronPresident, Medicare Advantage
    HUMHUMANA INC
    Grant or award
    A—
    17.0K sh
    Feb 12, 2026Feb 17, 2026
    traded Feb 12, 2026
    +5dSEC FORM 4

    Evidence

    9
    RA
    Rechtin James A.President & CEO
    HUMHUMANA INC
    Option exercise
    M—
    2,183 sh
    Jan 8, 2026Jan 12, 2026
    traded Jan 8, 2026
    +4dSEC FORM 4

    Evidence

    13
    RA
    Rechtin James A.President & CEO
    HUMHUMANA INC
    Option exercise
    M—
    2,183 sh
    Jan 8, 2026Jan 12, 2026
    traded Jan 8, 2026
    +4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002130908-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 1, 2026
    Published
    May 5, 2026
    Ingested by INSIDER
    Nov 5, 04:00 UTC
    Last re-read
    Nov 5, 04:00 UTC

    Extracted facts

    Filer
    Field Robert Stuart
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    HUMANA INC
    Ticker
    HUM
    Shares
    852
    Price per share
    $0
    Execution date (reported)
    May 1, 2026
    Owned after transaction
    852 shares
    Days from execution to publication
    4

    What this establishes

    Field Robert Stuart filed this Form 4 reporting a grant or award of HUM on May 1, 2026. It became public on May 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Field Robert Stuartcik:0002130908
    Issuer
    HUMANA INCcik:0000049071

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.